[1] Bueid A,Howard SJ,Moore CB,et al.Azole antifungal resist-ance in Aspergillus fumigatus:2008 and 2009[J].J AntimicrobChemother,2010,65(10):2116-2118. [2] 高青云,沈亮亮,施伟民,等.BP3抗耐氟康唑念珠菌活性研究[J].同济大学学报.2009,30(1):40-43. [3] 沈亮亮,叶元康.致病性真菌体外药物敏感性实验的方法[J].同济大学学报(增刊),2004,25:96-99. [4] 沈亮亮,叶元康.氟康唑与5-氟胞嘧啶体外联合抗白念珠菌临床分离株的临床研究[J].同济大学学报,2006,26(6):19-21. [5] 姜淼,黄欣,沈亮亮,等.2种中药单体念珠菌的体外药敏研究[J].中国真菌学杂志,2011,6(1):26-30. [6] 李岷,沈永年,吕桂霞,等.棘白霉素对氟康唑耐药的念珠菌体外药物敏感性的研究[J].中国真菌学杂志,2009,4(2):78-81. [7] Laverdiere M,LabbéAC,Restieri C,et,al.Susceptibility pat-terns of Candida species recovered from Canadian intensive careunits[J].J Crit Care,2007,22(3):245-250. [8] Howard SJ,Cerar D,Anderson MJ,et al.Frequency and evolu-tion of Azole resistance in Aspergillus fumigatus associated withtreatment failure[J].Emerg Infect Dis,2009,15(7):1068-1076. [9] Howard SJ,Harrison E,Bowyer P,et al.Cryptic species andazole resistance in the Aspergillus niger complex[J].AntimicrobAgents Chemother,2011,55(10):4802-4809. [10] Cuenca-Estrella M.Antifungal agents in the treatment of sys-temic infections:relevance of mechanism of action,activity pro-file and resistances[J].Rev Esp Quimioter,2010,23(4):169-176. [11] Chandra J,Kuhn DM,Mukherjec PK,et al.Biolfilm formationby the fungal pathogen Candida albicans development,archi-tecture,and drug resisence[J].J Bacteriol,2001,2001,183(18):5385-5394. [12] Hua Quan,Ying-Ying Cao,Zheng Xu,et al.Potent in vitrosynergism of fluconazole and berberine chloride against clinicalisolates of Candida albicans resistant to fluconazole[J].Anti-microbial Agents and Chemotherapy,2006,50(3):1096-1099. [13] 权华,赵靖霞,徐铮,等.盐酸小檗碱与氟康唑协同抗耐药白念珠菌的动物实验[J].实用医药杂志,2011,28(6):532-535. [14] 潘胜利,顺庆生,柏巧明主编.中国药用柴胡原色图志[M].上海:上海科学技术文献出版社,2002. |